Health Canada delays drug-pricing reforms, citing COVID challenges for manufacturers
Jan 7 2021 — Adina Bresge, The Canadian Press — Health Canada says it's delaying its long-awaited overhaul of drug-pricing regulations by another six months. While pharmaceutical manufacturers and patient advocates welcomed the decision, they say the federal government needs to go back to the drawing board for Canada to stay competitive in the global marketplace for medical innovation. A Health Canada spokesman confirmed to […]